Taipei Exchange - Delayed Quote TWD

Sea Mild Biotechnology Co., Ltd. (7516.TWO)

Compare
13.80 -0.10 (-0.72%)
At close: 2:41:52 PM GMT+8
Loading Chart for 7516.TWO
DELL
  • Previous Close 13.90
  • Open 13.90
  • Bid 13.40 x --
  • Ask 13.90 x --
  • Day's Range 12.60 - 13.90
  • 52 Week Range 8.20 - 14.60
  • Volume 450,603
  • Avg. Volume 142,687
  • Market Cap (intraday) 266.463M
  • Beta (5Y Monthly) -0.83
  • PE Ratio (TTM) 13.66
  • EPS (TTM) 1.01
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Sea Mild Biotechnology Co., Ltd. manufactures and sells paints, coatings, and detergents in Taiwan. It offers laundry, household, and personal detergent, as well as epidemic prevention products under the Sea Mild Biotech brand name. Sea Mild Biotechnology Co., Ltd. is headquartered in Taoyuan City, Taiwan.

www.seamild.com.tw

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 7516.TWO

View More

Performance Overview: 7516.TWO

Trailing total returns as of 1/8/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

7516.TWO
16.95%
TSEC CAPITALIZATION WEIGHTED ST
0.94%

1-Year Return

7516.TWO
18.97%
TSEC CAPITALIZATION WEIGHTED ST
33.61%

3-Year Return

7516.TWO
72.50%
TSEC CAPITALIZATION WEIGHTED ST
28.83%

5-Year Return

7516.TWO
23.13%
TSEC CAPITALIZATION WEIGHTED ST
97.03%

Compare To: 7516.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7516.TWO

View More

Valuation Measures

As of 1/7/2025
  • Market Cap

    267.43M

  • Enterprise Value

    278.52M

  • Trailing P/E

    13.71

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.99

  • Price/Book (mrq)

    3.10

  • Enterprise Value/Revenue

    1.03

  • Enterprise Value/EBITDA

    7.66

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.23%

  • Return on Assets (ttm)

    3.42%

  • Return on Equity (ttm)

    25.45%

  • Revenue (ttm)

    269.5M

  • Net Income Avi to Common (ttm)

    19.48M

  • Diluted EPS (ttm)

    1.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    63.42M

  • Total Debt/Equity (mrq)

    78.28%

  • Levered Free Cash Flow (ttm)

    2.51M

Research Analysis: 7516.TWO

View More